proDERM GmbH
11
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Evaluation of the Anti-aging Efficacy of One Face Care Cosmetic Product
Role: collaborator
Feasibility Study Focusing on Fit of Made-to-measure Compression Garments in Healthy Subjects II
Role: collaborator
Anti-Wrinkle Efficacy Study of an Eye-Cream
Role: collaborator
Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema
Role: collaborator
Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product
Role: collaborator
Evaluation of the Anti-aging Efficacy of Four Skin Health Products
Role: collaborator
Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness
Role: collaborator
A Clinical Investigation Into the Effectiveness and Safety of Five Water Based Personal Lubricants.
Role: collaborator
A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers
Role: collaborator
Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test
Role: collaborator
Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test
Role: collaborator
All 11 trials loaded